Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=25943887
&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests
in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215
Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 267.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 267.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\25943887
.jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117 Acta+Neuropathol
2015 ; 130
(1
): 63-75
Nephropedia Template TP
gab.com Text
Twit Text FOAVip
Twit Text #
English Wikipedia
Antisense RNA foci in the motor neurons of C9ORF72-ALS patients are associated
with TDP-43 proteinopathy
#MMPMID25943887
Cooper-Knock J
; Higginbottom A
; Stopford MJ
; Highley JR
; Ince PG
; Wharton SB
; Pickering-Brown S
; Kirby J
; Hautbergue GM
; Shaw PJ
Acta Neuropathol
2015[Jul]; 130
(1
): 63-75
PMID25943887
show ga
GGGGCC repeat expansions of C9ORF72 represent the most common genetic variant of
amyotrophic lateral sclerosis (ALS) and frontotemporal dementia. We and others
have proposed that RNA transcribed from the repeat sequence is toxic via
sequestration of RNA-binding factors. Both GGGGCC-repeat (sense) and
CCCCGG-repeat (antisense) molecules are detectable by fluorescence in situ
hybridisation as RNA foci, but their relative expression pattern within the CNS
and contribution to disease has not been determined. Blinded examination of CNS
biosamples from ALS patients with a repeat expansion of C9ORF72 showed that
antisense foci are present at a significantly higher frequency in cerebellar
Purkinje neurons and motor neurons, whereas sense foci are present at a
significantly higher frequency in cerebellar granule neurons. Consistent with
this, inclusions containing sense or antisense derived dipeptide repeat proteins
were present at significantly higher frequency in cerebellar granule neurons or
motor neurons, respectively. Immunohistochemistry and UV-crosslinking studies
showed that sense and antisense RNA molecules share similar interactions with
SRSF2, hnRNP K, hnRNP A1, ALYREF, and hnRNP H/F. Together these data suggest
that, although sense and antisense RNA molecules might be expected to be equally
toxic via their shared protein binding partners, distinct patterns of expression
in various CNS neuronal populations could lead to relative differences in their
contribution to the pathogenesis of neuronal injury. Moreover in motor neurons,
which are the primary target of pathology in ALS, the presence of antisense foci
(? (2), p < 0.00001) but not sense foci (? (2), p = 0.75) correlated with
mislocalisation of TDP-43, which is the hallmark of ALS neurodegeneration. This
has implications for translational approaches to C9ORF72 disease, and furthermore
interacting RNA-processing factors and transcriptional activators responsible for
antisense versus sense transcription might represent novel therapeutic targets.